S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Adar1 Capital Management/Q1 2024

Adar1 Capital Management

Period: Q1 2024 Β· Filed: 2024-05-15
View on SEC EDGAR β†—
AUM
$440M
Total portfolio value
Positions
261
Reported securities
Top Holding
ALNY
8.0% $35.0M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-05-15) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ALNYPUTALNYLAM PHARMACEUTICALS INC$35.0M7.95%$153.33$312.78+104.0%
8.0%
BOXXEA SERIES TRUST$33.9M7.68%$106.23$117.22+10.3%
7.7%
ROIVROIVANT SCIENCES LTD$29.4M6.68%$10.43$35.13+236.8%
6.7%
SPYPUTSPDR S&P 500 ETF TR$27.2M6.17%$508.44$744.78+46.5%
6.2%
ALNYALNYLAM PHARMACEUTICALS INC$26.9M6.11%$153.33$312.78+104.0%
6.1%
PTGXPROTAGONIST THERAPEUTICS INC$22.7M5.16%$28.28$131.62+365.4%
5.2%
CYTKCYTOKINETICS INC$22.4M5.08%$73.02$86.49+18.4%
5.1%
KROSKEROS THERAPEUTICS INC$22.4M5.08%$66.89$11.26-83.2%
5.1%
RPRXROYALTY PHARMA PLC$21.9M4.97%$28.22$57.77+104.7%
5.0%
BBIOBRIDGEBIO PHARMA INC$17.0M3.86%$29.98$77.19+157.5%
3.9%
MACKMERRIMACK PHARMACEUTICALS IN$13.3M3.02%β€”β€”
3.0%
ASNDASCENDIS PHARMA A/S$7.3M1.67%$151.98$274.50+80.6%
1.7%
ABUSARBUTUS BIOPHARMA CORP$5.3M1.21%$2.56$4.87+90.2%
1.2%
AVROAVROBIO INC$5.1M1.15%β€”β€”
1.1%
ONCBEIGENE LTD$4.9M1.12%$159.23$297.65+86.9%
1.1%
QQQPUTINVESCO QQQ TR$4.4M1.01%$439.63$712.60+62.1%
1.0%
ALKSALKERMES PLC$4.2M0.96%$27.24$54.58+100.4%
1.0%
HLXBHELIX ACQUISITION CORP II$4.2M0.95%β€”β€”
0.9%
SRPTSAREPTA THERAPEUTICS INC$4.0M0.91%$128.40$19.28-85.0%
0.9%
EDRENDEAVOR GROUP HLDGS INC$4.0M0.91%β€”β€”
0.9%
ACHVACHIEVE LIFE SCIENCES INC$4.0M0.90%$4.58$6.40+39.7%
0.9%
FUSNFUSION PHARMACEUTICALS INC$3.8M0.86%β€”β€”
0.9%
ABSIABSCI CORPORATION$3.3M0.76%$5.61$11.62+107.1%
0.8%
EWTXEDGEWISE THERAPEUTICS INC$3.3M0.75%$18.02$39.56+119.5%
0.8%
FULCFULCRUM THERAPEUTICS INC$3.2M0.73%$9.31$3.84-58.8%
0.7%
QTTBQ32 BIO INC$3.2M0.73%$18.00$13.09-27.3%
0.7%
APLTAPPLIED THERAPEUTICS INC$3.1M0.70%β€”β€”
0.7%
BILSPDR SER TR$3.0M0.68%$83.30$91.44+9.8%
0.7%
PFEPFIZER INC$3.0M0.67%$23.92$24.32+1.7%
0.7%
VUSBVANGUARD BD INDEX FDS$2.7M0.62%$44.50$49.64+11.6%
0.6%

Quarter-on-Quarter Activity

Q1 2024 vs. Q4 2023

New Positions (8)

TickerIssuerNotionalSince Filing
BOXXEA SERIES TRUST$33.9M+10.3%
SPYPUTSPDR S&P 500 ETF TR$27.2M+46.5%
QQQPUTINVESCO QQQ TR$4.4M+62.1%
ALKSALKERMES PLC$4.2M+100.4%
HLXBHELIX ACQUISITION CORP II$4.2M
ACHVACHIEVE LIFE SCIENCES INC$4.0M+39.7%
FUSNFUSION PHARMACEUTICALS INC$3.8M
ABSIABSCI CORPORATION$3.3M+107.1%

Exited Positions (8)

TickerIssuerNotional
MRTXMIRATI THERAPEUTICS INC$6.3M
KRTXKARUNA THERAPEUTICS INC$3.2M
AYXALTERYX INC$2.9M
IMGNIMMUNOGEN INC$1.9M
UTHRUNITED THERAPEUTICS CORP DEL$1.8M
SHYISHARES TR$1.2M
KVUEKENVUE INC$1.1M
ORTXORCHARD THERAPEUTICS PLC$1.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
ROIVROIVANT SCIENCES LTD$29.4M+69696.8%+236.8%
SLNSILENCE THERAPEUTICS PLC$0.9M+21000.0%
SLDBSOLID BIOSCIENCES INC$2.7M+20220.4%
CYTKCALLCYTOKINETICS INC$22.1M+9028.9%+18.4%
AVROAVROBIO INC$5.0M+7786.5%
EDRENDEAVOR GROUP HLDGS INC$3.9M+6110.0%
ARVNARVINAS INC$1.1M+3175.0%
SDGRSCHRODINGER INC$1.6M+3079.3%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
BBIOPUTBRIDGEBIO PHARMA INC$-7.4M-99.4%+157.5%
MRKMERCK & CO INC$-5.8M-99.4%
RLMDRELMADA THERAPEUTICS INC$-0.2M-99.0%
ARQTARCUTIS BIOTHERAPEUTICS INC$-0.8M-98.5%
NVONOVO-NORDISK A S$-0.6M-98.4%
ATXSASTRIA THERAPEUTICS INC$-1.4M-97.6%
CYTKCALLCYTOKINETICS INC$-7.5M-97.3%+18.4%
CYTKCALLCYTOKINETICS INC$-5.9M-96.6%+18.4%
← Back to Hedge Funds